SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 16th, 2018 • Zander Therapeutics, Inc • Pharmaceutical preparations • California
THIS SECURITIES PURCHASE AGREEMENT (the “Agreement”) is entered into by and among Zander Therapeutics, Inc., a Nevada corporation (the “Company”) whose address is 4700 Spring Street, St 304, La Mesa, California 91942 and Brian Devine, TTEE for the Devine Family Trust( “Purchaser”), a person whose address is _____________.
AGREEMENT BY AND BETWEEN REGEN BIOPHARMA, INC. AND ZANDER THERAPEUTICS, INC. Dated December 15, 2017License Agreement • January 16th, 2018 • Zander Therapeutics, Inc • Pharmaceutical preparations • California
WHEREAS, REGEN BIOPHARMA, INC. (“REGEN”) AND ZANDER THERAPEUTICS, INC. (“ZANDER”) ARE PARTIES TO THAT AGREEMENT DATED JUNE 23, 2015 WITH ZANDER WHEREBY REGEN GRANTED TO ZANDER AN EXCLUSIVE WORLDWIDE RIGHT AND LICENSE FOR THE DEVELOPMENT AND COMMERCIALIZATION OF ANY AND ALL INTELLECTUAL PROPERTY CONTROLLED BY REGEN (“LICENSE AGREEMENT”).
